Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Regulatory News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
807.00    -22.00 (-2.65%)
Bid:
812.00
Ask:
815.50
Spread: 3.50 (0.431%)
Market Cap: £918.95m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Director/PDMR Shareholding

15 Jul 2022 10:14

RNS Number : 6506S
Fevertree Drinks PLC
15 July 2022
 

Fevertree Drinks plc

 ("Fever-Tree" or the "Company")

 

Director/PDMR Shareholding

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces that on 15 July2022 Tim Warrillow, Co-Founder & Chief Executive Office, bought 115,000 ordinary shares in the Company at a price of £8.70887 per ordinary share.

For more information please contact:

Investor queries

Ann Hyams, Director of Investor Relations I ann.hyams@fever-tree.com I +44 (0)20 4516 8106

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024

 

Nominated Advisor and Joint Broker - Numis Securities

Stuart Dickson I Hugo Rubinstein I +44 (0)20 7260 1000

Joint Broker - Investec Bank plc

David Flin I Alex Wright I +44 (0)20 7597 5970

Financial PR advisers Finsbury

Faeth Birch +44 (0)7768 943 171; Anjali Unnikrishnan +44 (0)7826 534 233; Carolina Neri +44 (0)7502 127 516

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them in accordance with the Market Abuse Regulations

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Tim Warrillow

2

Reason for the notification

a)

Position/status

Co-Founder & Chief Executive Officer

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Fevertree Drinks plc

 

b)

LEI

2138007AJRLHRVQZLD07

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 0.25p each

 

 

 

GB00BRJ9BJ26

 

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

1.

£8.70887

115,000

 

d)

Aggregated information

 

n/a single trade

e)

Date of the transaction

15 July 2022

f)

Place of the transaction

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGCGDRXBBDGDU
Date   Source Headline
3rd Jul 20234:00 pmRNSTotal Voting Rights
1st Jun 20237:00 amRNSBlock Listing Return
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20231:54 pmRNSResult of AGM
25th May 20237:00 amRNSBoard Changes
25th May 20237:00 amRNSAGM Trading Statement
12th May 202311:25 amRNSHolding(s) in Company
5th May 20237:00 amRNSGrant of Options
2nd May 20237:00 amRNSTotal Voting Rights
21st Apr 20231:08 pmRNSNotice of AGM
22nd Mar 20237:00 amRNSFY22 Preliminary Results to 31 December 2022
8th Mar 20239:49 amRNSHolding(s) in Company
8th Feb 20232:56 pmRNSStandard form for notification of major holdings
30th Jan 20234:32 pmRNSHolding(s) in Company
26th Jan 20237:00 amRNSFY22 pre-close trading update
17th Jan 20239:45 amRNSStandard form for notification of major holdings
19th Dec 20227:00 amRNSBlock Admission Application
12th Dec 20227:00 amRNSDomenic De Lorenzo to succeed Bill Ronald as Chair
1st Dec 20229:00 amRNSBlock Listing Return
21st Nov 20227:00 amRNSChange Of Nominated Advisor and Corporate Broker
15th Nov 20226:18 pmRNSStandard form for notification of major holdings
1st Nov 20227:00 amRNSTotal Voting Rights
17th Oct 20223:09 pmRNSStandard form for notification of major holdings
4th Oct 202210:25 amRNSDirector/PDMR Shareholding
3rd Oct 20229:00 amRNSDirector/PDMR Shareholding
13th Sep 20227:00 amRNSFever-Tree FY22 Interim Results
1st Sep 20227:00 amRNSTotal Voting Rights
24th Aug 202212:06 pmRNSStandard form for notification of major holdings
19th Jul 20229:57 amRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSDirector/PDMR Shareholding
15th Jul 20224:00 pmRNSDirector/PDMR Shareholding
15th Jul 202210:14 amRNSDirector/PDMR Shareholding
15th Jul 20227:00 amRNSHY pre-close trading update
1st Jul 20222:26 pmRNSFever Tree drinks plc Total Voting Rights
29th Jun 20227:00 amRNSStandard form for notification of major holdings
10th Jun 20228:45 amRNSNOTIFICATION OF MAJOR HOLDINGS
1st Jun 20227:00 amRNSDirector/PDMR Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
31st May 20227:00 amRNSBlock Listing Return
23rd May 20223:00 pmRNSDirector/PDMR Shareholding
19th May 202212:57 pmRNSResult of Annual General Meeting
19th May 20227:00 amRNSTrading Update
3rd May 20227:00 amRNSRetirement of Chair of the Board
28th Apr 20224:00 pmRNSGrant of Options
21st Apr 20225:00 pmRNSStandard form for notification of major holdings
20th Apr 202211:58 amRNS2021 Annual Report and Notice of AGM
21st Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20227:00 amRNSCorrection to Dividend Shareholder Register Date
17th Mar 20224:23 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.